Skip to main content
. 2020 Feb 19;156(4):421–429. doi: 10.1001/jamadermatol.2020.0024

Table 1. Prevalence and Quality Assessment According to Different Cancer Types.

Group Studies, No. Patients, No. Prevalence, % (95% CI) Random Effects I2 (95% CI), % Cochran Q, df P Value
Cancer overall 41 1 214 030 4.78 (4.02-5.59) 99.3 (99.3-99.3) 5760.9940 <.001
Cancer excluding keratinocyte cancer 41 373 597 4.06 (3.31-4.87) 98.9 (98.8-98.9) 3555.8640 <.001
Keratinocyte cancer 48 374 895 2.55 (2.05-3.11) 99.1 (99.0-99.1) 5111.0047 <.001
Melanoma 31 519 267 0.31 (0.23-0.40) 94.4 (93.3-95.2) 534.4430 <.001
Lymphoma overall 28 1 598 836 0.25 (0.19-0.32) 96.8 (96.3-97.2) 837.2627 <.001
Non-Hodgkin lymphoma 13 395 213 0.30 (0.21-0.39) 92.5 (89.6-94.4) 161.0112 <.001
Hodgkin lymphoma 8 376 984 0.04 (0.02-0.06) 71.3 (25.2-84.4) 24.407 .001
Breast cancer 26 613 429 1.63 (1.23-2.08) 98.5 (98.3-98.6) 1619.1525 <.001
Lung cancer 29 825 435 0.87 (0.69-1.08) 97.6 (97.4-97.9) 1188.3328 <.001
Colon cancer 19 362 314 0.59 (0.44-0.75) 94.5 (93.1-95.5) 325.9618 <.001
Rectal cancer 8 135 220 0.27 (0.18-0.37) 84.1 (68.1-90.2) 44.007 <.001
Colorectal cancer 13 1 077 432 0.60 (0.47-0.76) 96.3 (95.3-97.0) 322.5712 <.001
Bladder cancer 18 959 642 0.34 (0.20-0.51) 94.7 (93.3-95.7) 320.0417 <.001
Psoriasis treated with biologic agents
Cancer overall 14 22 422 3.85 (2.69-5.20) 92.8 (90.2-94.5) 181.6513 <.001
Cancer excluding keratinocyte cancer 13 32 558 2.28 (1.64-3.02) 90.6 (86.3-93.1) 128.1212 <.001
Keratinocyte cancer 13 30 966 1.87 (1.30-2.54) 90.7 (86.5-93.2) 129.3812 <.001
Lymphoma overall 8 21 701 0.17 (0.08-0.31) 59.8 (0-79.7) 17.427 .01
Psoriatic arthritis
Cancer overall 13 39 608 5.74 (3.64-8.28) 98.6 (98.3-98.7) 837.0712 <.001
Cancer excluding keratinocyte cancer 7 13 507 3.59 (1.67-6.21) 96.9 (95.7-97.6) 192.086 <.001
Keratinocyte cancer 9 23 096 3.10 (1.24-5.76) 98.7 (98.5-98.9) 621.528 <.001
Melanoma 6 32 408 0.29 (0.17-0.44) 62.1 (0-82.4) 13.205 .02
Lymphoma overall 4 23 546 0.19 (0.09-0.31) 33.5 (0-77.5) 4.513 .21
Breast cancer 6 2546 1.63 (0.57-3.23) 76.9 (32.9-87.9) 21.685 <.001
Lung cancer 4 20 924 0.70 (0.18-1.54) 79.2 (9.9-90.3) 14.393 .002
Colorectal cancer 7 24 234 0.42 (0.21-0.69) 57.8 (0-79.8) 14.226 .03